| Product Code: ETC11945746 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Japan endovascular treatment devices market is witnessing significant growth driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in technology, and a growing aging population. The market encompasses a wide range of devices including stents, catheters, guidewires, and embolic protection devices, among others. With a strong emphasis on technological innovation and a high adoption rate of minimally invasive procedures, the demand for endovascular treatment devices in Japan is expected to continue rising. Key players in the market are focusing on product development and strategic partnerships to enhance their market presence. Additionally, the government`s initiatives to improve healthcare infrastructure and increase awareness about cardiovascular diseases are further contributing to the market`s expansion.
The Japan endovascular treatment devices market is experiencing a notable trend towards the adoption of advanced technologies such as drug-eluting stents, bioresorbable stents, and embolic protection devices. There is a growing emphasis on minimally invasive procedures, driving the demand for devices that offer improved precision, reduced recovery times, and better patient outcomes. The market is also witnessing an increasing focus on the development of specialized devices for complex procedures, such as endovascular aneurysm repair and peripheral vascular interventions. Additionally, there is a rising awareness among healthcare professionals and patients regarding the benefits of endovascular treatments over traditional surgical methods, leading to a steady growth in market size and revenue. These trends are expected to continue shaping the Japan endovascular treatment devices market in the coming years.
The Japan endovascular treatment devices market faces challenges such as strict regulatory requirements, limited reimbursement options for certain procedures, and a competitive landscape with both domestic and international players. The regulatory environment in Japan can be particularly stringent, requiring extensive clinical data and approvals which can slow down the introduction of new products. Additionally, the reimbursement system in Japan may not adequately cover the costs of certain endovascular procedures, leading to potential financial barriers for patients and healthcare providers. The market also experiences competition from established local manufacturers as well as global companies, making it crucial for companies to differentiate their products and services effectively to succeed in this market. Overall, navigating these challenges requires a deep understanding of the regulatory landscape, reimbursement policies, and competitive dynamics in Japan`s endovascular treatment devices market.
The Japan endovascular treatment devices market offers promising investment opportunities due to the increasing prevalence of cardiovascular diseases and the growing aging population in the country. Demand for minimally invasive procedures and advancements in endovascular technologies are driving market growth. Opportunities exist in segments such as stents, catheters, guide wires, and embolic protection devices. Companies investing in research and development to introduce innovative products catering to the specific needs of the Japanese market can gain a competitive edge. Strategic partnerships with healthcare providers and continued focus on regulatory compliance are essential for success in this market. Overall, the Japan endovascular treatment devices market presents a favorable investment landscape for those seeking to capitalize on the country`s healthcare market dynamics.
In Japan, the government has implemented various policies to regulate the endovascular treatment devices market. The Pharmaceutical and Medical Devices Act oversees the approval and post-market surveillance of these devices, ensuring their safety and efficacy. The Ministry of Health, Labour and Welfare (MHLW) also plays a critical role in setting reimbursement rates for medical procedures involving endovascular devices through the Diagnosis Procedure Combination (DPC) system. Additionally, the Japanese government encourages innovation in the medical device sector through initiatives such as the Regulatory Reform Promotion Council, which aims to streamline regulatory processes and expedite the approval of new technologies. Overall, these policies aim to promote patient safety, improve healthcare outcomes, and foster growth in the endovascular treatment devices market in Japan.
The Japan endovascular treatment devices market is expected to witness steady growth in the coming years. Factors driving this growth include the increasing prevalence of cardiovascular diseases, advancements in minimally invasive procedures, and a growing elderly population in Japan. Additionally, the rise in healthcare expenditure and technological innovations in endovascular devices are likely to contribute to market expansion. The market is forecasted to benefit from a shift towards less invasive treatment options and an increasing demand for improved patient outcomes. However, factors such as stringent regulatory requirements and high product costs may pose challenges to market growth. Overall, the Japan endovascular treatment devices market is anticipated to experience sustained growth opportunities in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Endovascular Treatment Devices Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Endovascular Treatment Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Endovascular Treatment Devices Market - Industry Life Cycle |
3.4 Japan Endovascular Treatment Devices Market - Porter's Five Forces |
3.5 Japan Endovascular Treatment Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Japan Endovascular Treatment Devices Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Japan Endovascular Treatment Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Endovascular Treatment Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cardiovascular diseases in Japan |
4.2.2 Technological advancements in endovascular treatment devices |
4.2.3 Growing demand for minimally invasive procedures in healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval in Japan |
4.3.2 High cost associated with endovascular treatment devices |
4.3.3 Limited reimbursement policies for endovascular procedures in Japan |
5 Japan Endovascular Treatment Devices Market Trends |
6 Japan Endovascular Treatment Devices Market, By Types |
6.1 Japan Endovascular Treatment Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Japan Endovascular Treatment Devices Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Japan Endovascular Treatment Devices Market Revenues & Volume, By Percutaneous endovascular aneurysm repair (EVAR), 2021 - 2031F |
6.1.4 Japan Endovascular Treatment Devices Market Revenues & Volume, By Fenestrated EVAR, 2021 - 2031F |
6.1.5 Japan Endovascular Treatment Devices Market Revenues & Volume, By Aortic stents Biodegradable Stents, 2021 - 2031F |
6.1.6 Japan Endovascular Treatment Devices Market Revenues & Volume, By Self-expanding Nitinol Stents, 2021 - 2031F |
6.1.7 Japan Endovascular Treatment Devices Market Revenues & Volume, By Thoracic aortic aneurysms grafts, 2021 - 2031F |
6.1.8 Japan Endovascular Treatment Devices Market Revenues & Volume, By Other Devices, 2021 - 2029F |
6.2 Japan Endovascular Treatment Devices Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Japan Endovascular Treatment Devices Market Revenues & Volume, By Balloon Angioplasty, 2021 - 2031F |
6.2.3 Japan Endovascular Treatment Devices Market Revenues & Volume, By Angioplasty with Stent Placement, 2021 - 2031F |
6.2.4 Japan Endovascular Treatment Devices Market Revenues & Volume, By Thrombolysis, 2021 - 2031F |
6.2.5 Japan Endovascular Treatment Devices Market Revenues & Volume, By Renal Artery Angioplasty and Stenting, 2021 - 2031F |
6.2.6 Japan Endovascular Treatment Devices Market Revenues & Volume, By Transfemoral Carotid Artery Stenting, 2021 - 2031F |
6.2.7 Japan Endovascular Treatment Devices Market Revenues & Volume, By Transcarotid Artery Revascularization, 2021 - 2029F |
6.2.8 Japan Endovascular Treatment Devices Market Revenues & Volume, By Others, 2021 - 2029F |
6.2.9 Japan Endovascular Treatment Devices Market Revenues & Volume, By Others, 2021 - 2029F |
6.3 Japan Endovascular Treatment Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Japan Endovascular Treatment Devices Market Revenues & Volume, By Pulmonary, 2021 - 2031F |
6.3.3 Japan Endovascular Treatment Devices Market Revenues & Volume, By Vascular, 2021 - 2031F |
6.3.4 Japan Endovascular Treatment Devices Market Revenues & Volume, By Cardiology Surgery, 2021 - 2031F |
6.3.5 Japan Endovascular Treatment Devices Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.6 Japan Endovascular Treatment Devices Market Revenues & Volume, By Radiology, 2021 - 2031F |
7 Japan Endovascular Treatment Devices Market Import-Export Trade Statistics |
7.1 Japan Endovascular Treatment Devices Market Export to Major Countries |
7.2 Japan Endovascular Treatment Devices Market Imports from Major Countries |
8 Japan Endovascular Treatment Devices Market Key Performance Indicators |
8.1 Adoption rate of endovascular treatment devices by hospitals and healthcare facilities |
8.2 Number of endovascular procedures performed annually in Japan |
8.3 Rate of complications and adverse events associated with endovascular treatments |
9 Japan Endovascular Treatment Devices Market - Opportunity Assessment |
9.1 Japan Endovascular Treatment Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Japan Endovascular Treatment Devices Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Japan Endovascular Treatment Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Endovascular Treatment Devices Market - Competitive Landscape |
10.1 Japan Endovascular Treatment Devices Market Revenue Share, By Companies, 2024 |
10.2 Japan Endovascular Treatment Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here